Talecris Biotherapeutics Holdings Corp.Research Triangle Park, NC, United States (NASDAQ (GS): TLCR)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Talecris Cash Flow Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 08 Dec 07 Dec 06
Net Operating Cash Flow 33.0 -- 138.0
Net Investing Cash Flow (111.9) -- (152.2)
Net Financing Cash Flow 22.6 -- 14.3
Net Change in Cash (56.5) -- 0.2
Depreciation & Amortization 20.3 -- --
Capital Expenditures (86.2) -- (38.9)
Cash Dividends Paid 0.0 -- (809.8)
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy